| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.54▲ | 1.53▲ | 1.53▲ | 1.65▼ | 1.85▼ |
| MA10 | 1.53▲ | 1.53▲ | 1.54▲ | 1.81▼ | 1.95▼ |
| MA20 | 1.52▲ | 1.55▲ | 1.55▼ | 1.78▼ | 2.60▼ |
| MA50 | 1.53▲ | 1.59▼ | 1.72▼ | 1.97▼ | 21.26▼ |
| MA100 | 1.55▲ | 1.74▼ | 1.83▼ | 3.48▼ | N/A |
| MA200 | 1.61▼ | 1.79▼ | 1.79▼ | 21.82▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | 0.005▲ | 0.008▲ | -0.011▼ | 0.824▲ |
| RSI | 65.167▲ | 48.769▼ | 43.074▼ | 38.808▼ | 25.962▼ |
| STOCH | 100.000▲ | 37.421 | 28.694 | 18.414▼ | 26.216 |
| WILL %R | 0.000▲ | -50.000 | -47.619 | -83.333▼ | -92.273▼ |
| CCI | 152.535▲ | 85.647 | -3.132 | -154.866▼ | -97.091 |
|
Wednesday, April 30, 2025 03:59 AM
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...
|
|
Tuesday, April 29, 2025 12:59 PM
In a turbulent market environment, QTTB stock has reached a 52-week low, trading at $2.44, marking a stark contrast to its 52-week ...
|
|
Friday, April 18, 2025 06:57 AM
In a report released on April 16, Thomas Smith from Leerink Partners maintained a Hold rating on Q32 Bio (QTTB – Research Report). The ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/05/25 | 1.54 | 1.56 | 1.49 | 1.55 | 204,221 |
| 30/04/25 | 1.52 | 1.65 | 1.43 | 1.60 | 1,109,572 |
| 29/04/25 | 1.67 | 1.71 | 1.52 | 1.56 | 306,394 |
| 28/04/25 | 1.89 | 1.935 | 1.66 | 1.685 | 318,793 |
| 25/04/25 | 1.92 | 1.995 | 1.82 | 1.87 | 70,794 |
| 24/04/25 | 1.89 | 1.92 | 1.83 | 1.85 | 91,467 |
| 23/04/25 | 1.98 | 1.98 | 1.87 | 1.90 | 117,970 |
| 22/04/25 | 2.07 | 2.085 | 1.90 | 1.91 | 207,607 |
| 21/04/25 | 2.15 | 2.15 | 2.01 | 2.03 | 211,056 |
| 17/04/25 | 1.83 | 2.14 | 1.81 | 2.12 | 108,269 |
|
|
||||
|
|
||||
|
|